WARNING: This product contains nicotine.
Nicotine is an addictive chemical.

Know Your Nicotine: Cancer-Causing Compounds (Carcinogens)

on August 10, 2022

The combustion of tobacco yields several different cancer-causing compounds, also known as carcinogens. Four commonly cited carcinogenic compounds that are heavily present in traditional cigarette smoke include acrolein, benzene, acrylonitrile, and crotonaldehyde. Researchers often measure biomarkers of these four carcinogenic compounds to determine whether or not something is safe to consume, and commonly find that combustion cigarette smokers consume statistically-significantly have higher levels of all four of these carcinogens.  With the inception of electronic nicotine vaporizers, the presence of these carcinogens in users of nicotine can be significantly lowered.  

One study suggests that people who consume any nicotine vaporizer device will have significantly lower biomarkers for the presence of carcinogens in their system as compared to traditional combustion cigarette smokers, but this may not be enough to prevent harmful exposure to cancer-causing chemicals. According to this study, acrolein is still present in significantly higher quantities in users who use any vaporizer device as compared to users who do not smoke or vape, underscoring the importance of being selective when shopping for your nicotine device.

Unlike other devices on the market, SMOOD vaporizers use the highest purity of synthetic s-nicotine, which does not contain the harmful impurities often found in tobacco and other tobacco-derived ingredients, and maintains a better toxicological profile than its isomer, r-nicotine. SMOOD manufactures devices using medical-grade nicotine only, under medical-device standards, and with the help of pharmaceutical engineers, is proud to guarantee that carcinogens, including acrolein, are not detected in any of the vapor produced by our devices.  

As we gain a better understanding of how vapes differ from traditional cigarette smoke, SMOOD is looking to partner with a research facility to run studies in-vivo using SMOOD vapes, as we are confident that the carcinogenic intake of our vape users is at parity with that of non-smokers.  


Please note, comments must be approved before they are published